Is Symproic a controlled substance?
Medically reviewed by Drugs.com. Last updated on Oct 28, 2020.
No, Symproic (naldemedine) is not a controlled substance.
In September 2017, naldemedine was reclassified by the DEA removing it from classification as a schedule II narcotic (a drug that can be abused or lead to drug-seeking behavior and addiction) to no schedule.
Symproic is an oral medication used to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. Keep this medicine in a safe place to prevent misuse and abuse.
- Symproic Information for Consumers
- Symproic Information for Healthcare Professionals (includes dosage details)
- Side Effects of Symproic (detailed)